Related references
Note: Only part of the references are listed.Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity
Anna Gatti et al.
ORGANOMETALLICS (2018)
Domain-Specific Association of a Phenanthrene-Pyrene-Based Synthetic Fluorescent Probe with Bovine Serum Albumin: Spectroscopic and Molecular Docking Analysis
Mihir Sasmal et al.
ACS OMEGA (2018)
New Class of Half-Sandwich Ruthenium(II) Arene Complexes Bearing the Water-Soluble CAP Ligand as an in Vitro Anticancer Agent
Antonella Guerriero et al.
INORGANIC CHEMISTRY (2017)
Water soluble Ru(II)-arene complexes of the antidiabetic drug metformin: DNA and protein binding, molecular docking, cytotoxicity and apoptosis-inducing activity
Durairaj Gopalakrishnan et al.
RSC ADVANCES (2017)
The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials
Leli Zeng et al.
CHEMICAL SOCIETY REVIEWS (2017)
The discovery of half-sandwich iridium complexes containing lidocaine and (pyren-1-yl) ethynyl derivatives of phenylcyanamide ligands for photodynamic therapy
Leila Tabrizi
DALTON TRANSACTIONS (2017)
Platinum-based drugs: past, present and future
Shahana Dilruba et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Photo-induced DNA cleavage and cytotoxicity of a ruthenium(II) arene anticancer complex
Viktor Brabec et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Synthesis, structures, and DNA and protein binding of ruthenium(II)-p-cymene complexes of substituted pyridylimidazo[1,5-a] pyridine: enhanced cytotoxicity of complexes of ligands appended with a carbazole moiety
Themmila Khamrang et al.
RSC ADVANCES (2016)
Ruthenium(II) arene complexes containing benzhydrazone ligands: synthesis, structure and antiproliferative activity
Mohamed Kasim Mohamed Subarkhan et al.
INORGANIC CHEMISTRY FRONTIERS (2016)
Fluorescent mixed ligand copper(II) complexes of anthracene-appended Schiff bases: studies on DNA binding, nuclease activity and cytotoxicity
Paramasivam Jaividhya et al.
DALTON TRANSACTIONS (2015)
A hypoxia efficient imidazole-based Ru(II) arene anticancer agent resistant to deactivation by glutathione
Kallol Purkait et al.
DALTON TRANSACTIONS (2015)
The state-of-play and future of platinum drugs
Michael G. Apps et al.
ENDOCRINE-RELATED CANCER (2015)
Ru(II)-Catalyzed β-Carboline Directed C-H Arylation and Isolation of Its Cycloruthenated Intermediates
Subramani Rajkumar et al.
JOURNAL OF ORGANIC CHEMISTRY (2015)
Combination of Ru(II) complexes and light: new frontiers in cancer therapy
Cristina Mari et al.
CHEMICAL SCIENCE (2015)
Synthesis, DNA/protein binding, molecular docking, DNA cleavage and in vitro anticancer activity of nickel(II) bis(thiosemicarbazone) complexes
Jebiti Haribabu et al.
RSC ADVANCES (2015)
Recent advances in supramolecular and biological aspects of arene ruthenium(II) complexes
Ashish Kumar Singh et al.
COORDINATION CHEMISTRY REVIEWS (2014)
New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity
Mani Ganeshpandian et al.
DALTON TRANSACTIONS (2014)
In vivo anti-tumor activity of the organometallic ruthenium(II)-arene complex [Ru(η6-p-cymene)-Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
Andrea Weiss et al.
CHEMICAL SCIENCE (2014)
Selective Catalytic Deuterium Labeling of Alcohols during a Transfer Hydrogenation Process of Ketones Using D2O as the Only Deuterium Source. Theoretical and Experimental Demonstration of a Ru-H/D+ Exchange as the Key Step
M. Carmen Carrion et al.
ACS CATALYSIS (2014)
Interaction of mixed ligand copper(II) complexes with CT DNA and BSA: Effect of primary ligand hydrophobicity on DNA and protein binding and cleavage and anticancer activities
Mani Ganeshpandian et al.
POLYHEDRON (2013)
Atomic force microscopy study of DNA conformation in the presence of drugs
Valeria Cassina et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2011)
Piano-Stool Complexes of Ruthenium(II) Designed with Arenes and N-[2-(Arylchalcogeno)ethyl]morpholines: Highly Active Catalysts for the Oxidation of Alcohols with N-Methylmorpholine N-Oxide, tert-Butyl Hydroperoxide and Sodium Periodate and Oxychloride
Pradhumn Singh et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2010)
Versatile Behavior of the Schiff Base Ligand 2,5-Me2C6H3C(H)=N(2,4,6-Me3C6H2) toward Cyclometalation Reactions: C(sp2,phenyl)-H vs C(sp3,methyl)-H Activation
Digna Vazquez-Garcia et al.
ORGANOMETALLICS (2010)
OLEX2: a complete structure solution, refinement and analysis program
Oleg V. Dolomanov et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2009)
Photophysics and photochemistry of photodynamic therapy: fundamental aspects
K. Plaetzer et al.
LASERS IN MEDICAL SCIENCE (2009)
Effect of derivatization of sulfamethoxazole and trimethoprim with copper and zinc on their medicinal value
Mohammad S. Iqbal et al.
MEDICINAL CHEMISTRY RESEARCH (2009)
Mechanistic Study of Acetate-Assisted C-H Activation of 2-Substituted Pyridines with [MCl2CP*]2 (M = Rh, Ir) and [RuCl2(p-cymene)]2
Youcef Boutadla et al.
ORGANOMETALLICS (2009)
KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
Christian G. Hartinger et al.
CHEMISTRY & BIODIVERSITY (2008)
Chiral pyridylamino-ruthenium(II) complexes: synthesis, structure and catalytic properties in Diels-Alder reactions
Daniel Carmona et al.
DALTON TRANSACTIONS (2008)
A Fluorinated Ruthenium Porphyrin as a Potential Photodynamic Therapy Agent: Synthesis, Characterization, DNA Binding, and Melanoma Cell Studies
Sandya Rani-Beeram et al.
INORGANIC CHEMISTRY (2008)
Differences in structure, physiological stability, electrochemistry, cytotoxicity, DNA and protein binding properties between two Ru(III) complexes
Caiping Tan et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
Chemotherapy-induced neuropathy
Anthony J. Windebank et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2008)
The promotion of secondary structures in single-stranded DNA by drugs that bind to duplex DNA: an atomic force microscopy study
Jozef Adamcik et al.
NANOTECHNOLOGY (2008)
A short history of SHELX
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Controlling ligand substitution reactions of organometallic complexes:: Tuning cancer cell cytotoxicity
FY Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cytotoxicity of enantiomers of gossypol Schiff's bases and optical stability of gossypolone
VT Dao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Single-crystal structure validation with the program PLATON
AL Spek
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2003)
Chiral protein scissors: High enantiomeric selectivity for binding and its effect on protein photocleavage efficiency and specificity
CV Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Organometallic ruthenium(II) diamine anticancer complexes: Arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts
HM Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Photophysics of Re(I) and Ru(II) diimine complexes covalently linked to pyrene: Contributions from intra-ligand charge transfer states
A Del Guerzo et al.
INORGANIC CHEMISTRY (2002)
Inhibition of cancer cell growth by ruthenium(II) arene complexes
RE Morris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Se-methylselenocysteine induces apoptosis through caspase activation in HL-60 cells
T Kim et al.
CARCINOGENESIS (2001)
Share Paper
